>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
腹腔感染中的相关病原菌及其特点
作者:黄金健1 2  任建安1 2 
单位:1. 东南大学医学院, 江苏 南京 210009;
2. 南京军区总医院 普通外科, 江苏 南京 210002
关键词:腹腔感染 细菌种类 耐药率 危险因素 综述 
分类号:R63
出版年·卷·期(页码):2018·37·第二期(350-354)
摘要:

随着腹部手术的增多以及创伤事件的增加,腹腔感染在临床上越来越常见,因此,熟知腹腔感染中病原菌的种类及其耐药情况,对于理解感染源控制的重要性以及早期经验性抗生素的选择具有十分重要的意义。

参考文献:

[1] 张波,曾庆东,李胜,等.胰十二指肠切除术后腹腔感染发生的影响因素[J].中国普通外科杂志,2004,13(2):127-129.
[2] 肖华,欧阳永忠,汤明,等.胃癌根治术后腹腔感染的危险因素分析[J].中华医学杂志,2013,93(40):3211-3214.
[3] CURRIE J,LIN W,MENG J.Addressing antibiotic abuse in China:an experimental audit study[J].J Dev Econ,2014,110:39-51.
[4] SARTELLI M,CATENA F,di SAVERIO S,et al.The challenge of antimicrobial resistance in managing intra-abdominal infections[J].Surg Infect (Larchmt),2015,16(3):213-220.
[5] ZHANG S,HUANG W.Epidemiological study of community-and hospital-acquired intraabdominal infections[J].Chin J Traumatol,2015,18(2):84-89.
[6] YANG Q,WANG H,CHEN M,et al.Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in China:the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART)[J].Int J Antimicrob Agents,2010,36(6):507-512.
[7] 赵春江,陈宏斌,王辉,等.2013年全国13所教学医院院内血流感染及院内获得性肺炎和院内获得性腹腔感染常见病原菌分布和耐药性研究[J].中华医学杂志,2015,95(22):1739-1746.
[8] 王昊,吴大玮,尹梅,等.腹部手术后并发念珠菌血行感染患者临床特征和死亡危险因素分析[J].中华普通外科杂志,2015,30(1):50-53.
[9] CARNEIRO H A,MAVRAKIS A,MYLONAKIS E.Candida peritonitis:an update on the latest research and treatments[J].World J Surg,2011,35(12):2650-2659.
[10] 马筱玲,鲁怀伟,张艳.认识细菌的天然耐药和获得性耐药[J].中华检验医学杂志,2012,35(8):762-763.
[11] BARLOW M,HALL B G.Predicting evolutionary potential:in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase[J].Genetics,2002,160(3):823-832.
[12] HOOPER D C,JACOBY G A.Mechanisms of drug resistance:quinolone resistance[J].Ann N Y Acad Sci,2015,1354:12-31.
[13] WANG S,ZHAO S Y,XIAO S Z,et al.Antimicrobial resistance and molecular epidemiology of Escherichia coli causing bloodstream infections in three hospitals in Shanghai,China[J].PLoS One,2016,11(1):e147740.
[14] LIANG C,XING B,YANG X,et al.Molecular epidemiology of aminoglycosides resistance on Klebsiella pneumonia in a hospital in China[J].Int J Clin Exp Med,2015,8(1):1381-1385.
[15] CHEN Z,NIU H,CHEN G,et al.Prevalence of ESBLs-producing Pseudomonas aeruginosa isolates from different wards in a Chinese teaching hospital[J].Int J Clin Exp Med,2015,8(10):19400-19405.
[16] SHEN J L,FANG Y P.Detection of drug-resistance mechanism of Pseudomonas aeruginosa developing from a sensitive strain to a persister during carbapenem treatment[J].Genet Mol Res,2015,14(2):6723-6732.
[17] SHEN J,PAN Y,FANG Y.Role of the outer membrane protein OprD2 in carbapenem-resistance mechanisms of Pseudomonas aeruginosa[J].PLoS One,2015,10(10):e139995.
[18] 祝剑虹.生物膜与血管内导管相关感染的机制[J].肠外与肠内营养,2010,17(5):297-301.
[19] 王岚,刘新,周园,等.医用导管内鲍氏不动杆菌生物膜与ICU医院感染相关性研究[J].中华医院感染学杂志,2010,20(20):3081-3084.
[20] DAURY L,ORANGE F,TAVEAU J C,et al.Tripartite assembly of RND multidrug efflux pumps[J].Nat Commun,2016,7:10731.
[21] ZHANG H,YANG Q,XIAO M,et al.Antimicrobial susceptibility of Gram-negative bacteria causing intra-abdominal infections in China:SMART China 2011[J].Chin Med J (Engl),2014,127(13):2429-2433.
[22] YANG Q,ZHANG H,WANG Y,et al.A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community-and hospital-associated intra-abdominal infections in China[J].J Med Microbiol,2013,62(Pt 9):1343-1349.
[23] 陈宏斌,赵春江,王辉,等.2011年中国13家教学医院院内感染常见病原菌耐药性分析[J].中华内科杂志,2013,52(3):203-212.
[24] 裴标,刘玉娥,高峻,等.一株极广谱耐药的肺炎克雷伯菌引起手术感染的病原学实验研究[J].中国卫生检验杂志,2000,10(6):741-742.
[25] YAN Q,ZHOU M,ZOU M,et al.Hypervirulent Klebsiella pneumoniae induced ventilator-associated pneumonia in mechanically ventilated patients in China[J].Eur J Clin Microbiol Infect Dis,2016,35(3):387-396.
[26] LIU Y M,LI B B,ZHANG Y Y,et al.Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China[J].Antimicrob Agents Chemother,2014,58(9):5379-5385.
[27] HAWSER S P,BOUCHILLON S K,LASCOLS C,et al.Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates[J].Antimicrob Agents Chemother,2011,55(8):3917-3921.
[28] YANG Q,ZHANG H,WANG Y,et al.A 10 year surveillance for antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae in community-and hospital-associated intra-abdominal infections in China[J].J Med Microbiol,2013,62(Pt 9):1343-1349.
[29] 杨启文,王辉,徐英春,等.中国14家教学医院院内菌血症与肺炎和腹腔感染病原菌的抗生素耐药监测[J].中华检验医学杂志,2009,32(12):1367-1375.
[30] YANG J,JIANG Y,GUO L,et al.Prevalence of diverse clones of vancomycin-resistant enterococcus faecium ST78 in a Chinese hospital[J].Microb Drug Resist,2015,22(4):294-300.
[31] 崔宇慧,唐建国.真菌对临床抗真菌药物的耐药机制[J].中国抗生素杂志,2011,36(10):733-737.
[32] 任建安.腹腔真菌感染[J].中国感染与化疗杂志,2011,11(2):111.
[33] SHIELDS R K,NGUYEN M H,PRESS E G,et al.Abdominal candidiasis is a hidden reservoir of echinocandin resistance[J].Antimicrob Agents Chemother,2014,58(12):7601-7605.
[34] 李云,李忠涛,夏正武,等.呼吸道真菌感染的流行病学调查及耐药性监测分析[J].实用预防医学,2012,19(4):591-593.
[35] 李云,夏正武,李忠涛,等.泌尿系真菌感染的流行病学调查及耐药性监测分析[J].现代预防医学,2013(7):1330-1331,1335.
[36] OTEO J,PEREZ-VAZQUEZ M,CAMPOS J.Extended-spectrum[beta]-lactamase producing Escherichia coli:changing epidemiology and clinical impact[J].Curr Opin Infect Dis,2010,23(4):320-326.
[37] SWENSON B R,METZGER R,HEDRICK T L,et al.Choosing antibiotics for intra-abdominal infections:what do we mean by "high risk"?[J].Surg Infect (Larchmt),2009,10(1):29-39.
[38] MONTRAVERS P,DUFOUR G,GUGLIELMINOTTI J,et al.Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis[J].Crit Care,2015,19:70.
[39] SEGUIN P,FEDUN Y,LAVIOLLE B,et al.Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care[J].J Antimicrob Chemother,2010,65(2):342-346.
[40] WU C T,CHEN C L,LEE H Y,et al.Decreased antimicrobial resistance and defined daily doses after implementation of a clinical culture-guided antimicrobial stewardship program in a local hospital[J].J Microbiol Immunol Infect,2017,50(6):846-856.
[41] SAWYER R G,CLARIDGE J A,NATHENS A B,et al.Trial of short-course antimicrobial therapy for intraabdominal infection[J].N Engl J Med,2015,372(21):1996-2005.
[42] MASEDA E,SUAREZ-DE-LA-RICA A,ANILLO V,et al.Procalcitonin-guided therapy may reduce length of antibiotic treatment in intensive care unit patients with secondary peritonitis:a multicenter retrospective study[J].J Crit Care,2015,30(3):537-542.
[43] 周会霞,杨广龙,李银华.血清降钙素原监测对小儿细菌感染性肺炎合理使用抗生素的指导[J].现代医学,2017,36(3):401-405.
[44] WUN Y T,LAM T P,LAM K F,et al.The public's perspectives on antibiotic resistance and abuse among Chinese in Hong Kong[J].Pharmacoepidemiol Drug Saf,2013,22(3):241-249.
[45] POPOVSKI Z,MERCURI M,MAIN C,et al.Multifaceted intervention to optimize antibiotic use for intra-abdominal infections[J].J Antimicrob Chemother,2015,70(4):1226-1229.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 412075 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364